{
  "meta": {
    "title": "Parathyroid_Bone_Mineral_Disorders",
    "url": "https://brainandscalpel.vercel.app/parathyroid-bone-mineral-disorders-19f5b423.html",
    "scrapedAt": "2025-11-30T11:13:17.054Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteopetrosis</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudohypoparathyroidism</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman with a 10-year history of chronic renal insufficiency secondary to bilateral obstructive hydronephrosis presented for evaluation of pain in the right hip. She had undergone bilateral ureterostomies, but her creatinine level remained chronically elevated. An X-ray revealed a fracture of the right femoral neck necessitating internal fixation. The X-ray hand also showed resorption of the middle phalanx of fingers. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1198039",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>This patient's clinical features renal failure, hip fracture, and resorption of phalanges</strong> <strong>are classic for secondary hyperparathyroidism due to renal osteodystrophy.</strong></p>\r\n<ul>\r\n<li><strong>In chronic </strong>renal failure:\r\n<ul>\r\n<li>Phosphate retention leads to hyperphosphatemia</li>\r\n<li>Reduced 1&alpha;-hydroxylase activity causes low calcitriol, impairing calcium absorption</li>\r\n<li>These lead to hypocalcemia, stimulating parathyroid hormone (PTH) release</li>\r\n<li>Chronic stimulation causes secondary hyperparathyroidism</li>\r\n</ul>\r\n</li>\r\n<li>Radiological hallmark: Subperiosteal bone resorption, especially in phalanges</li>\r\n<li>Pathologic fractures (e.g. femoral neck) are common due to bone demineralisation</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Renal osteodystrophy includes:</strong>\r\n<ul>\r\n<li><strong>Osteitis fibrosa cystica (high bone turnover due to hyperparathyroidism)</strong></li>\r\n<li><strong>Adynamic bone disease</strong></li>\r\n<li><strong>Osteomalacia</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Treatment: dietary phosphate binders, vitamin D analogues, calcimimetics</strong></li>\r\n<li><strong>Tertiary hyperparathyroidism can develop after prolonged secondary hyperparathyroidism</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Osteoporosis (Option A): Usually affects postmenopausal women; does not cause phalangeal resorption or occur secondary to renal failure.</strong></p>\r\n<p><strong>Osteopetrosis (Option B): A congenital disorder of osteoclast dysfunction; presents with brittle bones, pancytopenia, and cranial nerve palsies not seen here.</strong></p>\r\n<p><strong>Pseudohypoparathyroidism (Option C): Involves PTH resistance; presents with hypocalcemia and skeletal abnormalities, but not with renal disease and phalangeal resorption.</strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Subperiosteal bone resorption and fractures in a renal failure patient point toward secondary hyperparathyroidism from renal osteodystrophy.</strong></p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget's disease</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteomalacia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old woman complains of muscle aches and pains and difficulty standing up. Investigations show: <br> Serum calcium 7.2 mg/dl (Low) <br> Phosphate 2.6 mg/dl (normal) <br> Albumin 3.6 g/dL<br> Alkaline phosphatase 380 IU/L (30-230) <br> The most likely diagnosis is:</span></p>",
      "unique_key": "DT1198042",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198042,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>The biochemical profile and symptoms are classic for osteomalacia, which results from vitamin D deficiency leading to impaired mineralisation of osteoid.</strong></p>\r\n<ul>\r\n<li>Hypocalcemia and raised ALP are hallmark features</li>\r\n<li>Phosphate may be normal or low, depending on aetiology</li>\r\n<li>Proximal myopathy causes difficulty in standing or climbing stairs</li>\r\n<li>Bone pain and deformity are due <strong>to accumulation of unmineralized osteoid</strong></li>\r\n<li><strong>Increased ALP reflects increased osteoblastic activity attempting to </strong>mineralise<strong> defective bone</strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Common causes: Vitamin D deficiency, chronic renal disease, phosphate depletion</strong></li>\r\n<li><strong>Radiologic features: Looser's zones (pseudofractures), cortical thinning</strong></li>\r\n<li><strong>Treatment: Vitamin D and calcium supplementation</strong></li>\r\n<li><strong>Distinguished from osteoporosis by abnormal labs and presence of osteoid</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Primary hyperparathyroidism (Option A): Typically causes hypercalcemia and hypophosphatemia not seen here.</strong></p>\r\n<p><strong>Paget's disease (Option B): Shows markedly elevated ALP but normal calcium and phosphate levels; often asymptomatic or with </strong>localised<strong> bone deformities.</strong></p>\r\n<p><strong>Osteoporosis (Option C): Affects bone density; all lab values (Ca, PO4, ALP) are usually normal, unlike in this case.</strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Low calcium + raised ALP in an elderly woman with proximal myopathy strongly suggests osteomalacia due to vitamin D deficiency.</strong></p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary thyroid carcinoma</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Parathyroid adenoma</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Parathyroid carcinoma</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary thyroid carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old woman presented with vomiting. Blood tests reveal high parathyroid hormone levels and hypercalcaemia. Which one of the following is most likely to have caused primary hyperparathyroidism?</span></p>",
      "unique_key": "DT1198043",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198043,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The <strong>most common cause</strong> of <strong>primary hyperparathyroidism</strong> is a <strong>parathyroid adenoma</strong>, accounting for <strong>80-85%</strong> of cases.</p>\r\n<ul>\r\n<li>Presents with PTH-dependent hypercalcemia (&uarr;Ca&sup2;+ and &uarr;PTH)</li>\r\n<li>Symptoms: nausea, vomiting, constipation, polyuria, neuropsychiatric complaints (\"bones, stones, groans, and psychiatric overtones\")</li>\r\n<li>Adenomas are benign monoclonal proliferations of parathyroid chief cells</li>\r\n<li>Diagnosis: elevated serum calcium + elevated or inappropriately normal PTH</li>\r\n<li>Other causes include parathyroid hyperplasia (10-15%) and carcinoma (&lt;1%)</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Familial hypocalciuric hypercalcemia (FHH) and lithium therapy are other causes of PTH-dependent hypercalcemia</li>\r\n<li>PTH-independent hypercalcemia causes: malignancy, vitamin D intoxication, granulomatous disease, thiazides</li>\r\n<li>Initial management includes hydration, loop diuretics, and definitive parathyroidectomy</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Medullary thyroid carcinoma (Option A):</strong> Secretes <strong>calcitonin</strong>, not PTH; may rarely cause <strong>hypocalcemia</strong>.</p>\r\n<p><strong>Parathyroid carcinoma (Option C):</strong> A rare cause of primary hyperparathyroidism (&lt;1%) and usually presents with <strong>very high calcium</strong> (&gt;14 mg/dL) and <strong>palpable neck mass</strong>.</p>\r\n<p><strong>Papillary thyroid carcinoma (Option D):</strong> Most common thyroid malignancy, but <strong>unrelated</strong> to calcium or PTH regulation.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Parathyroid adenoma</strong> is the <strong>most common cause</strong> of <strong>primary hyperparathyroidism</strong>, typically presenting with <strong>PTH-dependent hypercalcemia</strong>.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">She has suffered predominantly cortical bone loss</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">She has probably suffered an equal mix of cortical and trabecular bone loss</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">She has probably suffered predominantly trabecular bone loss</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Underlying hyperparathyroidism will have contributed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The Ortho department refers a 58-year-old woman after attending with a vertebral fracture, the second in the last 3 years. She underwent a total hysterectomy with oophorectomy at the age of 38 for carcinoma. Bone densitometry confirms osteoporosis. The calcium and parathyroid hormone assays are within normal limits. Which of the following is the most likely concerning her underlying pathophysiology?</span></p>",
      "unique_key": "DT1198048",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This is a case of <strong>postmenopausal osteoporosis</strong> due to <strong>estrogen deficiency</strong> following <strong>surgical menopause</strong> at age 38.</p>\r\n<ul>\r\n<li>Estrogen deficiency causes increased bone resorption, primarily affecting trabecular (spongy) bone, which is abundant in vertebrae, leading to early vertebral fractures.</li>\r\n<li>Trabecular bone is metabolically more active and more sensitive to hormonal changes than cortical bone.</li>\r\n<li>This explains multiple vertebral fractures despite normal calcium and PTH levels.</li>\r\n<li>Involutional (senile) osteoporosis affects both cortical and trabecular bone, whereas postmenopausal osteoporosis predominantly affects trabecular bone.</li>\r\n<li>Normal PTH rules out primary or secondary hyperparathyroidism.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Risk factors</strong>: Early menopause, hysterectomy with oophorectomy, age, family history</li>\r\n<li><strong>Diagnosis</strong>: Bone mineral density (T-score &le; -2.5)</li>\r\n<li><strong>Treatment</strong>:\r\n<ul>\r\n<li><strong>Bisphosphonates, denosumab</strong> (antiresorptive)</li>\r\n<li><strong>Teriparatide</strong> (anabolic) for severe cases</li>\r\n</ul>\r\n</li>\r\n<li>Hormone therapy is now limited due to <strong>thromboembolic</strong> and <strong>cancer risks</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>She has suffered predominantly cortical bone loss (Option A):</strong> Cortical bone is primarily affected in <strong>senile osteoporosis</strong>, not early estrogen-deficient states.</p>\r\n<p><strong>She has probably suffered an equal mix of cortical and trabecular bone loss (Option B):</strong> Mixed loss is more typical of <strong>involutional osteoporosis</strong> in the elderly, not in surgically menopausal women.</p>\r\n<p><strong>Underlying hyperparathyroidism will have contributed (Option D):</strong> <strong>PTH is normal</strong>, ruling out hyperparathyroidism as a contributor in this case.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Estrogen deficiency</strong> after early oophorectomy leads to <strong>trabecular bone loss</strong>, making <strong>vertebral fractures</strong> common.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudohypoparathyroidism</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudo-pseudohypoparathyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old woman was admitted 2 days ago with seizures. She has a history of moderate alcohol use and was recently treated with benzathine penicillin for secondary syphilis. She is now on phenytoin, paracetamol, multivitamins, and chlordiazepoxide. On examination, she has a round face, short neck, short 4th and 5th metacarpals, and bilateral cataracts. Laboratory results reveal: <br> 1.\tSerum calcium: 6.9 mg/dL (&darr;)<br> 2.\tSerum phosphate: 6 mg/dL (&uarr;)<br> 3.\tPTH: 200 pg/mL (&uarr;&uarr;)<br> What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1198050",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198050,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>This patient exhibits features of Albright's hereditary osteodystrophy (AHO)</strong> <strong>short stature, </strong>brachydactyly, and soft tissue calcification along with hypocalcemia, hyperphosphatemia, and markedly elevated PTH, which are hallmark features of pseudohypoparathyroidism (PHP) Type 1a.</p>\r\n<ul>\r\n<li><strong>PH</strong>P is due to end-organ resistance to PTH caused by a mutation in the Gs alpha protein of the PTH receptor pathway.</li>\r\n<li>Despite elevated PTH, there is no renal response, so phosphate is retained and calcium is not reabsorbed.</li>\r\n<li>Bilateral cataracts and seizures are consequences of chronic hypocalcemia.</li>\r\n<li>In contrast, pseudo-pseudohypoparathyroidism has similar skeletal features but normal labs.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Inheritance: Autosomal dominant with imprinting (paternal imprinting in pseudo-PHP)</strong></li>\r\n<li><strong>G-protein resistance can also affect TSH and gonadotropin signalling, causing hypothyroidism and hypogonadism</strong></li>\r\n<li><strong>Treatment involves </strong>calcium and active vitamin D supplementation</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Hypothyroidism (Option A): May coexist in PHP but cannot explain the biochemical findings of hypocalcemia with elevated PTH.</strong></p>\r\n<p><strong>Hypoparathyroidism (Option C): Characterised by low or absent PTH, not elevated PTH levels.</strong></p>\r\n<p><strong>Pseudo-pseudohypoparathyroidism (Option D): Shows AHO phenotype but normal calcium, phosphate, and PTH levels.</strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Elevated PTH with hypocalcemia and Albright phenotype confirms pseudohypoparathyroidism due to PTH resistance.</strong></p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretion is inhibited by hypocalcemia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretion is stimulated by hypophosphatemia</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">The effect of magnesium on secretion is the same as that of calcium</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretion is stimulated by low 1,25-hydroxyvitamin D and inhibited by high levels of 1,25-hydroxyvitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding parathyroid hormone (PTH)?</span></p>",
      "unique_key": "DT1198055",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198055,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Parathyroid hormone (PTH) secretion is primarily regulated by <strong>serum calcium levels</strong>, but <strong>1,25-dihydroxyvitamin D</strong> also provides feedback control.</p>\r\n<ul>\r\n<li>High 1,25(OH)2D levels suppress PTH gene transcription and secretion directly via vitamin D receptors on parathyroid cells.</li>\r\n<li>Low levels of 1,25(OH)2D remove this inhibition, stimulating PTH secretion.</li>\r\n<li>Additionally, hypocalcemia is the most potent stimulator of PTH secretion, while hypercalcemia suppresses it.</li>\r\n<li>Hypomagnesemia impairs PTH release, not mimicking calcium's effect.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202404124ed5a4da-d31d-4ad3-9586-36495e8670fd.jpg\">\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>PTH acts on bone, kidney, and indirectly on intestine (via 1,25(OH)2D) to increase serum calcium</li>\r\n<li><strong>Phosphate</strong> directly regulates PTH only mildly; hypophosphatemia doesn't strongly stimulate PTH secretion</li>\r\n<li>PTH increases renal phosphate excretion while promoting calcium reabsorption</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Secretion is inhibited by hypocalcemia (Option A): </strong>Hypocalcemia strongly stimulates PTH secretion.</p>\r\n<p><strong>Secretion is stimulated by hypophosphatemia (Option B):</strong> Hyperphosphatemia, not hypophosphatemia, mildly stimulates PTH.</p>\r\n<p><strong>The effect of magnesium on secretion is the same as that of calcium (Option C):</strong> Severe hypomagnesemia inhibits PTH secretion, unlike calcium.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>1,25-dihydroxyvitamin D</strong> provides <strong>negative feedback</strong> on PTH secretion-<strong>high levels inhibit</strong>, and <strong>low levels stimulate</strong> PTH release.</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone replacement</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D supplementation</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonate therapy</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man comes to see you for chronic back pain, which worsened 1 week ago. He has been wheelchair bound for 6 months because of severe osteoporosis with multiple lumbosacral spine fractures. He has severe asthma, which has required large doses of glucocorticoids for many years. The patient reports progressive loss of height and kyphosis over the past year. Significant physical findings include bilateral cataracts, multiple ecchymoses and a prolonged expiratory phase with bilateral wheezes. Which of the following treatments is the first choice in this patient?</span></p>",
      "unique_key": "DT1198058",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198058,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient has glucocorticoid-induced osteoporosis, a common and serious complication of chronic steroid use.</p>\r\n<ul>\r\n<li>Glucocorticoids promote bone resorption and reduce osteoblast activity, leading to trabecular bone loss, particularly in the spine and ribs.</li>\r\n<li>Bisphosphonates are the first-line treatment for glucocorticoid-induced osteoporosis.\r\n<ul>\r\n<li>They reduce bone resorption by inhibiting osteoclasts.</li>\r\n<li>Zoledronic acid (IV yearly) and alendronate/risedronate (oral weekly) are commonly used.</li>\r\n</ul>\r\n</li>\r\n<li>Vitamin D and calcium are adjunctive but insufficient alone.</li>\r\n<li>This patient&rsquo;s features (fragility fractures, kyphosis, cataracts, steroid use) make bisphosphonates the appropriate initial therapy.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Risk factors for glucocorticoid-induced osteoporosis:\r\n<ul>\r\n<li> &ge;5 mg prednisolone for &gt;3 months</li>\r\n<li>Age &gt;65</li>\r\n<li>Low BMI</li>\r\n<li>History of fragility fractures</li>\r\n</ul>\r\n</li>\r\n<li>Alternatives if bisphosphonates are contraindicated:\r\n<ul>\r\n<li>Denosumab (if renal impairment)</li>\r\n<li>Teriparatide (anabolic agent for severe cases)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Testosterone replacement (Option A): </strong>Reserved for men with proven hypogonadism; not first-line for steroid-induced osteoporosis.</p>\r\n<p><strong>Vitamin D supplementation (Option B): </strong>Essential but not sufficient alone; used as adjunct with anti-resorptives.</p>\r\n<p><strong>Calcitonin therapy (Option D): </strong>Now rarely used; has limited efficacy and is not recommended as first-line.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Bisphosphonates are the first-line treatment for glucocorticoid-induced osteoporosis, especially in patients with fragility fractures.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased bone formation</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased bone loss</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased calcium absorption from the gastrointestinal (GI) tract</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following mechanisms is responsible for glucocorticoid-induced osteoporosis?</span></p>",
      "unique_key": "DT1198062",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198062,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Glucocorticoids induce osteoporosis via multiple mechanisms, making this a multifactorial metabolic bone disease.</strong></p>\r\n<ul>\r\n<li><strong>Decreased bone formation:</strong>\r\n<ul>\r\n<li><strong>Glucocorticoids dire</strong>ctly suppress osteoblast proliferation and increase osteoblast apoptosis, reducing b<strong>one formation.</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Increased bone loss:</strong>\r\n<ul>\r\n<li><strong>They promot</strong>e osteoclast survival and bone resorption, especially in trabecular bone (e.g. vert<strong>ebral bodies).</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Decreased calcium absorption from the GI tract:</strong>\r\n<ul>\r\n<li><strong>Glucocorticoi</strong>ds impair intestinal calcium absorption and increase urinary calcium loss, leading to secondary hyperparathyroidism, which accelerates bone resorption.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>These combined effects</strong> lead to rapid bone loss, particularly in the first 6 months of steroid therapy.</p>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Risk increases with higher steroid doses, longer duration, and in the elderly</li>\r\n<li>Vertebral fractures are the most common complication</li>\r\n<li>Prevention and treatment: Calcium + Vitamin D + anti-resorptives (e.g., bisphosphonates)</li>\r\n<li>Also associated with hypogonadism, contributing further to bone loss</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Decreased bone formation (Option A): </strong>Occurs due to osteoblast suppression one major mechanism.</p>\r\n<p><strong>Increased bone loss (Option B):</strong> Caused by increased osteoclast activity and secondary hyperparathyroidism.</p>\r\n<p><strong>Decreased GI calcium absorption (Option C):</strong> Glucocorticoids inhibit intestinal calcium uptake, a key contributor.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Glucocorticoid-induced osteoporosis results from combined effects on bone formation, bone resorption, and calcium homeostasis.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Continued physical activity</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of positive family history</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-smoker</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Overweight condition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old overweight woman constable presents with amenorrhoea of 6 months' duration. There is no family history of osteoporosis or fracture. She does not smoke and is a teetotaler. Blood tests: FSH 35 IU/l (postmenopausal level > 30), LH 57 IU/l (Postmenopausal level > 30). Bone density measurements with a DEXA scan are within normal limits. What is the chief reason that this woman has not developed osteoporosis?</span></p>",
      "unique_key": "DT1198064",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198064,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The <strong>overweight status</strong> is the most significant protective factor in this woman against osteoporosis.</p>\r\n<ul>\r\n<li>Adipose tissue expresses aromatase, which converts androstenedione to estrone&mdash;the main estrogen form after menopause.</li>\r\n<li>In overweight women, increased aromatisation leads to higher circulating estrone, providing estrogenic protection against bone resorption.</li>\r\n<li>This compensatory estrone production delays or prevents postmenopausal osteoporosis, even in the setting of ovarian failure.</li>\r\n<li>Though other factors (e.g. non-smoking, physical activity) contribute, adiposity-induced estrogen production is most crucial in this case.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Estrone is a weaker estrogen, but remains significant post-menopause</li>\r\n<li>Estrogen deficiency accelerates osteoclast-mediated bone loss</li>\r\n<li>DEXA scan (T-score &gt; &ndash;1) confirms preserved bone mineral density</li>\r\n<li>Weight-bearing activity and lifestyle also influence bone health, but were not the dominant factor here</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Continued physical activity (Option A):</strong> Helps maintain bone mass, but <strong>not the primary reason</strong> in overweight postmenopausal women.</p>\r\n<p><strong>Absence of positive family history (Option B):</strong> Reduces genetic risk but doesn&rsquo;t actively promote bone mass.</p>\r\n<p><strong>Non-smoker (Option C):</strong> Smoking accelerates bone loss, so absence is beneficial but <strong>not sufficient alone</strong> to explain preserved BMD.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Obesity protects against osteoporosis due to increased peripheral conversion of androgens to estrone via aromatase in adipose tissue.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Dual-energy X-ray absorptiometry</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">X-ray of long bones</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone scintigraphy</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Quantitative computed tomography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old woman is undergoing investigations for secondary amenorrhoea and joint pains. Blood tests show her follicle-stimulating hormone level to be 40 IU/l (> 30 in postmenopausal women). What would be the best method for diagnosing osteoporosis in this patient?</span></p>",
      "unique_key": "DT1198071",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198071,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient is likely <strong>perimenopausal or menopausal</strong>, as suggested by elevated FSH levels. The <strong>gold standard</strong> for diagnosing osteoporosis is <strong>Dual-energy X-ray absorptiometry (DXA)</strong>.</p>\r\n<ul>\r\n<li>DXA provides a <strong>T-score</strong> comparing the patient's bone mineral density (BMD) to that of a healthy young adult.\r\n<ul>\r\n<li><strong>T-score &le; -2.5</strong>: Osteoporosis</li>\r\n<li><strong>T-score between -1.0 and -2.5</strong>: Osteopenia</li>\r\n</ul>\r\n</li>\r\n<li>DXA is <strong>non-invasive, reproducible</strong>, and <strong>widely available</strong>, making it ideal for both <strong>diagnosis</strong> and <strong>monitoring</strong> treatment response.</li>\r\n<li>It measures BMD at <strong>lumbar spine and femoral neck</strong>, which are key fracture sites.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>FRAX score</strong> may be used along with DXA to assess 10-year fracture risk</li>\r\n<li>Other investigations (e.g. labs, imaging) are done to rule out <strong>secondary causes</strong></li>\r\n<li><strong>Menopause</strong>, due to estrogen deficiency, is a major risk factor for accelerated bone loss</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>X-ray of long bones (Option B):</strong> Detects fractures but is <strong>insensitive for early bone loss</strong> and cannot quantify BMD.</p>\r\n<p><strong>Bone scintigraphy (Option C):</strong> Useful for <strong>detecting active bone turnover or metastases</strong>, not for diagnosing osteoporosis.</p>\r\n<p><strong>Quantitative computed tomography (Option D):</strong> More sensitive than DXA but <strong>less accessible</strong>, <strong>higher radiation exposure</strong>, and <strong>not standard</strong> for diagnosis.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>DXA scan</strong> is the <strong>gold standard</strong> for diagnosing <strong>osteoporosis</strong>, especially in <strong>postmenopausal women</strong>.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypomagnesemia</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D deficiency</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Dietary calcium deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 74-year-old woman was brought in by her daughter for a complete physical examination. Her complaints include a poor appetite, weight loss, cramps and weakness. She was diagnosed with Crohn's disease 10 years ago but is not taking any medications. Routine evaluation showed a serum calcium of 7 mg/dl with normal phosphate. She has a creatinine of 0.8 mg/dl, albumin is 3.5 g/dl (normal range, 3.7-4.9 g/dl) and alkaline phosphatase is 350 U/l (normal range, 50-200 U/l). Which of the following diagnoses is most compatible with these lab data?</span></p>",
      "unique_key": "DT1198076",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198076,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The most compatible diagnosis is <strong>vitamin D deficiency</strong>, commonly caused by <strong>malabsorption</strong> in patients with <strong>Crohn&rsquo;s disease</strong>, especially when the <strong>terminal ileum</strong> is involved.</p>\r\n<ul>\r\n<li>Vitamin D deficiency leads to <strong>reduced intestinal calcium absorption</strong>, causing <strong>hypocalcemia</strong>.</li>\r\n<li>To compensate, the body develops <strong>secondary hyperparathyroidism</strong>, which maintains normal phosphate (or causes mild hypophosphatemia) and <strong>elevated ALP</strong> due to increased bone turnover.</li>\r\n<li>Crohn&rsquo;s disease impairs absorption of <strong>fat-soluble vitamins</strong> (A, D, E, K), contributing to low vitamin D levels.</li>\r\n<li><strong>Elevated ALP</strong> is a marker of <strong>increased osteoblastic activity</strong> and is commonly seen in <strong>osteomalacia</strong> secondary to vitamin D deficiency.</li>\r\n</ul><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040848ca9d1c-3b7d-4070-9471-bf85534e0d76.jpg\">\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Other causes of vitamin D deficiency: lack of sunlight, chronic kidney disease, poor dietary intake</li>\r\n<li>Classic lab pattern: <strong>low calcium</strong>, <strong>normal or low phosphate</strong>, <strong>elevated ALP</strong>, and <strong>normal creatinine</strong></li>\r\n<li>Management: vitamin D and calcium supplementation, nutritional optimisation</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Hypoparathyroidism (Option A):</strong> Typically shows <strong>low calcium and high phosphate</strong> with <strong>low or inappropriately normal PTH</strong>, not expected here.</p>\r\n<p><strong>Hypomagnesemia (Option B):</strong> Can impair PTH secretion, but phosphate is usually <strong>low</strong>, and ALP is not elevated.</p>\r\n<p><strong>Dietary calcium deficiency (Option D):</strong> Would cause <strong>mild hypocalcemia</strong>, but alone would not explain <strong>elevated ALP</strong> or such a clinical picture in the presence of Crohn-related malabsorption.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>In elderly patients with <strong>Crohn's disease</strong> and <strong>low calcium with elevated ALP</strong>, always suspect <strong>vitamin D deficiency due to fat-soluble vitamin malabsorption</strong>.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Celiac disease</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1 diabetes mellitus</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcaemia</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman presented with painful oral ulcers. Her mother had a history of thyroidectomy. Which of the following would suggest polyglandular syndrome type 1?</span></p>",
      "unique_key": "DT1198082",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198082,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Hypocalcaemia, secondary to hypoparathyroidism, is seen in ~90% of patients with polyglandular syndrome type 1 and is a key diagnostic feature.</p>\r\n<p>Autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive disorder caused by mutations in the AIRE gene.</p>\r\n<ul>\r\n<li><strong>The classic triad includes:</strong>\r\n<ul>\r\n<li>Mucocutaneous candidiasis (seen in 100%)</li>\r\n<li>Hypoparathyroidism (90%) &rarr; leads to hypocalcaemia</li>\r\n<li>Primary adrenal insufficiency (60%)</li>\r\n</ul>\r\n</li>\r\n<li><strong>Other features:</strong>\r\n<ul>\r\n<li>Primary gonadal failure</li>\r\n<li>Primary hypothyroidism</li>\r\n<li>Ectodermal dystrophy</li>\r\n<li>Autoimmune hepatitis, vitiligo, malabsorption</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>In this case, oral ulcers could be due to mucocutaneous candidiasis, and hypocalcaemia is strongly suggestive of underlying hypoparathyroidism.</p>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Celiac disease (Option A): </strong>More commonly associated with APS-2, not a key feature of APS-1.</p>\r\n<p><strong>Type 1 diabetes mellitus (Option B): </strong>Also associated with APS-2, but not a core component of APS-1.</p>\r\n<p><strong>Hypercalcaemia (Option D): </strong>Opposite of what is seen in hypoparathyroidism, which causes hypocalcaemia.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Hypocalcaemia due to autoimmune hypoparathyroidism is a hallmark of polyglandular autoimmune syndrome type 1.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung cancer with bony mets</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man presents with bony pain that has been present for some months, particularly affecting his left femur, pelvis and lower back. Blood testing reveals normal serum calcium and phosphorus levels, but a raised alkaline phosphatase level. X-rays of the femur and pelvis reveal mixed lytic and sclerotic change, with accentuated trabecular markings. Chest X-ray is normal. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1198088",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198088,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Mixed lytic-sclerotic bone lesions with elevated ALP and normal calcium/phosphorus strongly suggest Paget's disease.</p>\r\n<p>Paget's disease of bone is a chronic disorder characterised by abnormal bone remodelling, affecting ~2% of individuals over 55 years of age.</p>\r\n<ul>\r\n<li>It progresses through three radiologic phases:\r\n<ul>\r\n<li>Lytic phase</li>\r\n<li>Mixed lytic and sclerotic phase</li>\r\n<li>Sclerotic phase</li>\r\n</ul>\r\n</li>\r\n<li>Radiological features:\r\n<ul>\r\n<li>Flame sign/blade of grass in long bones</li>\r\n<li>Ivory vertebra</li>\r\n<li>Cotton wool skull</li>\r\n<li>Mickey Mouse pelvis</li>\r\n</ul>\r\n</li>\r\n<li>Labs:\r\n<ul>\r\n<li> &uarr; Alkaline phosphatase (ALP) (marker of bone turnover)</li>\r\n<li>Normal calcium and phosphate</li>\r\n</ul>\r\n</li>\r\n<li>Treatment: IV bisphosphonates (e.g., zoledronic acid)</li>\r\n<li>Complications: fractures, deafness (skull involvement), high-output cardiac failure, and rare transformation to osteosarcoma</li>\r\n</ul>\r\n<p>Explanation of other options:</p>\r\n<p>Lung cancer with bony mets (Option A): Typically causes lytic or blastic lesions, but usually with elevated calcium, not isolated ALP elevation and no systemic signs here.</p>\r\n<p>Multiple myeloma (Option B): Causes punched-out lytic lesions, often with hypercalcemia and low ALP.</p>\r\n<p>Hypoparathyroidism (Option C): Associated with low calcium, high phosphate, and does not cause bony pain or ALP elevation.</p>\r\n<p>Key Takeaway:</p>\r\n<p>Paget's disease presents with bony pain, raised ALP, and mixed radiographic lesions, most commonly affecting the pelvis, spine, and femur.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Ask her to breathe into a paper bag</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous calcium</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous diazepam</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You got a reference from the Surgical dept to see a 36-year-old woman on the surgical ward who is 2 days post-thyroidectomy. She is complaining of tingling around her mouth and in her hands and has developed a spasm in her hands. What immediate treatment can you give that is most likely to resolve her symptoms?</span></p>",
      "unique_key": "DT1198091",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198091,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>IV calcium gluconate is the immediate treatment of choice for acute symptomatic hypocalcaemia after thyroid surgery.</p>\r\n<p>The patient has acute hypocalcaemia following thyroidectomy, most likely due to transient or inadvertent removal of parathyroid glands.</p>\r\n<ul>\r\n<li>Symptoms: Perioral tingling, carpopedal spasm, Chvostek/Trousseau sign, and muscle cramps</li>\r\n<li>This is a classic postoperative complication, especially within 48&ndash;72 hours of surgery</li>\r\n<li>Treatment:\r\n<ul>\r\n<li>10 mL of 10% calcium gluconate IV slowly relieves acute symptoms</li>\r\n<li>Long-term: oral calcium + activated vitamin D (calcitriol) if hypocalcaemia is persistent</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Ask her to breathe into a paper bag (Option A): </strong>This may help alleviate respiratory alkalosis from hyperventilation, but is not effective for true hypocalcaemia.</p>\r\n<p><strong>Intravenous diazepam (Option C): </strong>Used for muscle spasms due to seizures, but not for electrolyte imbalance.</p>\r\n<p><strong>Intravenous glucose (Option D): </strong>Used for hypoglycemia, not hypocalcaemia.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>IV calcium gluconate is the emergency treatment for acute symptomatic hypocalcaemia following thyroid surgery.</strong></p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernatraemia</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercalcaemia</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalaemia</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old chronic smoker presents with polyuria, polydipsia and altered sensorium for the past 2 days. He is known to be suffering from squamous-cell carcinoma of the lung. On examination, he is lethargic and confused. ECG shows a narrowed QT interval. What is the most probable metabolic abnormality?</span></p>",
      "unique_key": "DT1198095",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198095,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Hypercalcaemia due to PTHrP secretion is a common paraneoplastic complication of squamous cell carcinoma of the lung, and it causes shortened QT interval.</p>\r\n<ul>\r\n<li>This patient's symptoms and background strongly suggest paraneoplastic hypercalcaemia, commonly associated with squamous cell carcinoma of the lung.</li>\r\n<li>Caused by ectopic production of parathyroid hormone-related peptide (PTHrP)</li>\r\n<li>Classical symptoms:\r\n<ul>\r\n<li>Polyuria, polydipsia (due to nephrogenic DI-like effect)</li>\r\n<li>Altered sensorium, lethargy, confusion</li>\r\n</ul>\r\n</li>\r\n<li>ECG finding: shortened QT interval</li>\r\n<li>Other complications:\r\n<ul>\r\n<li>Dehydration</li>\r\n<li>Pre-renal AKI</li>\r\n<li>Acute pancreatitis</li>\r\n<li>Encephalopathy</li>\r\n</ul>\r\n</li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024041261feae52-a9a1-4a6a-9cae-92f97ff4f36a.jpg\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Hypernatraemia (Option A): </strong>May cause CNS symptoms, but does not explain QT interval changes or occur commonly with squamous lung carcinoma.</p>\r\n<p><strong>Hypokalaemia (Option C): </strong>Causes U waves and flattened T waves, not QT shortening; not paraneoplastic in this context.</p>\r\n<p><strong>Hypocalcaemia (Option D): </strong>Causes QT prolongation, not shortening, and is not associated with squamous cell carcinoma.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Squamous cell lung carcinoma frequently causes hypercalcaemia via PTHrP, presenting with neuro, renal, and ECG changes, including shortened QT.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Milk alkali syndrome</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased hydroxylation of vitamin D</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">PTHrP mediated</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old man with established sarcoidosis presents for review. He suffers from a degree of pulmonary fibrosis due to previous pulmonary infiltration and has been taking corticosteroids intermittently. His serum calcium concentration is 12.5 mg/dl. His renal function is normal, and parathyroid hormone is just below the lower end of the normal range. What is the most likely cause of his hypercalcaemia?</span></p>",
      "unique_key": "DT1198096",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198096,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Hypercalcemia in sarcoidosis is most commonly due to increased extrarenal 1&alpha;-hydroxylation of vitamin D by activated macrophages within granulomas, leading to excess 1,25-dihydroxyvitamin D and increased calcium absorption.</p>\r\n<ul>\r\n<li>The low-normal PTH confirms PTH-independent hypercalcemia.</li>\r\n<li>Sarcoid granulomas produce 1&alpha;-hydroxylase, bypassing kidney regulation.</li>\r\n<li>This leads to hyperabsorption of calcium from the gut, predisposing to hypercalcemia and hypercalciuria.</li>\r\n<li>Steroids help inhibit granulomatous activity and vitamin D hydroxylation.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Other granulomatous diseases that may cause hypercalcemia via the same mechanism include:\r\n<ul>\r\n<li>Tuberculosis</li>\r\n<li>Histoplasmosis</li>\r\n<li>Berylliosis</li>\r\n</ul>\r\n</li>\r\n<li>Chronic hypercalcemia in sarcoidosis may lead to nephrocalcinosis or renal stones.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Hyperparathyroidism (Option A): </strong>PTH is suppressed and not inappropriately high.</p>\r\n<p><strong>Milk alkali syndrome (Option B): </strong>Causes hypercalcaemia + metabolic alkalosis + renal dysfunction; renal function is normal here.</p>\r\n<p><strong>PTHrP mediated (Option D): </strong>Seen in malignancies (e.g., squamous cell carcinoma), not in sarcoidosis.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Sarcoidosis causes hypercalcaemia due to excess extrarenal 1-&alpha; hydroxylation of vitamin D by macrophages, leading to PTH-independent hypercalcaemia.</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits osteoblast activity</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates osteoblast activity</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulates osteoclast activity</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits osteoclast activity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 59-year-old woman is taking alendronate for osteoporosis. She visits the clinic and is keen to discuss the mechanism of action of this class of drugs as she has been studying them on the Internet. Which of the following options best describes the mode of action of the bisphosphonate class of agents?</span></p>",
      "unique_key": "DT1198105",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198105,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Bisphosphonates, such as alendronate, work primarily by <strong>inhibiting osteoclast-mediated bone resorption</strong>, thereby reducing bone turnover and increasing bone mineral density.</p>\r\n<ul>\r\n<li>They bind strongly to hydroxyapatite in bone.</li>\r\n<li>When osteoclasts resorb bone, they take up bisphosphonates, which:\r\n<ul>\r\n<li><strong>Induce apoptosis</strong> in osteoclasts</li>\r\n<li><strong>Suppress osteoclast recruitment and function</strong></li>\r\n</ul>\r\n</li>\r\n<li>This leads to reduced bone loss and improved structural integrity of bone.</li>\r\n</ul>\r\n<p><strong>Examples of bisphosphonates:</strong></p>\r\n<ul>\r\n<li><strong>Oral:</strong> Alendronate, Risedronate, Ibandronate</li>\r\n<li><strong>IV:</strong> Zoledronate (most potent; used once yearly)</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Oral bisphosphonates must be taken <strong>on an empty stomach with water</strong> and the patient must <strong>remain</strong> upright for 30-60 minutes to prevent esophagitis.</li>\r\n<li>Adverse effects include oesophagal ulceration, osteonecrosis of the jaw, and atypical femoral fractures with long-term use.</li>\r\n<li>Alternative agents: Denosumab, Raloxifene, Teriparatide, Romosozumab (depending on patient profile).</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240408b9e251d1-df4b-494d-a8f1-e06e142601b3.jpg\"><p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Inhibits osteoblast activity (Option A):</strong> Osteoblasts are responsible for bone formation; bisphosphonates do <strong>not inhibit</strong> them.</p>\r\n<p><strong>Stimulates osteoblast activity (Option B):</strong> This is seen with <strong>anabolic agents</strong> like <strong>teriparatide</strong>.</p>\r\n<p><strong>Stimulates osteoclast activity (Option C):</strong> This would <strong>worsen bone loss</strong>, the opposite of bisphosphonate action.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Bisphosphonates act by inhibiting osteoclast activity</strong>, thereby reducing bone resorption and improving bone strength in osteoporosis.</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial hypercalcaemic hypocalciuria</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoparathyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 46-year-old woman has attended the emergency department on several occasions this year because of renal tract stones. She has also suffered depression during the past year or two. She is found to have a serum calcium of 13 mg/dl, creatinine of 1.3 mg/dl and albumin of 4.0 g/dl. What is her most likely underlying diagnosis?</span></p>",
      "unique_key": "DT1198106",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198106,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient presents with symptomatic hypercalcemia (renal stones, neuropsychiatric symptoms), and a significantly elevated serum calcium level (13 mg/dL) with normal albumin, which is highly suggestive of primary hyperparathyroidism (PHPT).</p>\r\n<ul>\r\n<li>PHPT is the most common cause of hypercalcemia in ambulatory patients.</li>\r\n<li>Renal stones, bone pain, abdominal discomfort, and psychiatric symptoms (\"stones, bones, groans, and psychiatric overtones\") are classical signs.</li>\r\n<li>PHPT is due to parathyroid adenoma (80-85%), parathyroid hyperplasia, or rarely, carcinoma.</li>\r\n<li>Elevated PTH levels (which would be expected but are not provided here) help confirm the diagnosis.</li>\r\n</ul>\r\n<p>Related Important Points:</p>\r\n<ul>\r\n<li>PHPT is associated with MEN1 and MEN2A syndromes.</li>\r\n<li>In MEN1, hyperparathyroidism coexists with pituitary adenomas and pancreatic neuroendocrine tumours.</li>\r\n<li>Surgical management is indicated in symptomatic patients or when calcium &gt;1 mg/dL above the upper limit of normal.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Familial hypercalcaemic hypocalciuria (Option B):</strong> Features mild hypercalcaemia with low urinary calcium, often asymptomatic, not associated with stones.</p>\r\n<p><strong>Sarcoidosis (Option C): </strong>Causes PTH-independent hypercalcaemia via increased 1&alpha;-hydroxylase, but typically with other systemic features; less common in outpatient hypercalcaemia.</p>\r\n<p><strong>Hypoparathyroidism (Option D): </strong>Causes hypocalcaemia, not hypercalcaemia, ruled out by high serum calcium here.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Primary hyperparathyroidism should be suspected in outpatient hypercalcaemia with renal stones and neuropsychiatric features.</p>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">He has hyperparathyroidism that is likely to have been cured by the surgery</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary calcium excretion is increased</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Inheritance is autosomal dominant</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute pancreatitis is commonly associated with the condition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man presents with a serum calcium concentration of 12.5 mg/dl, and urinary calcium excretion of 12 mg/24 h. There is no history of renal stones, pancreatitis, depression or any prior illness. He underwent parathyroidectomy. Which of the following is true of the disease which underlies this man's case history?</span></p>",
      "unique_key": "DT1198108",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198108,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Familial hypocalciuric hypercalcaemia (FHH) is an autosomal dominant disorder with inappropriately low urinary calcium in the setting of hypercalcaemia.</p>\r\n<ul>\r\n<li>This clinical picture is consistent with FHH, a rare, benign genetic disorder due to inactivating mutations in the calcium-sensing receptor (CaSR).</li>\r\n<li>Key features:\r\n<ul>\r\n<li>Mild to moderate hypercalcaemia</li>\r\n<li>Low urinary calcium excretion (&lt;100 mg/day or Ca/Cr ratio &lt;0.01)</li>\r\n<li>Elevated or inappropriately normal PTH</li>\r\n</ul>\r\n</li>\r\n<li>Inheritance is autosomal dominant with high penetrance</li>\r\n<li>Parathyroidectomy is ineffective in FHH and should generally be avoided</li>\r\n<li>The condition is usually asymptomatic, though rare cases with pancreatitis have been reported (mostly in homozygotes)</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>He has hyperparathyroidism that is likely to have been cured by the surgery (Option A): </strong>FHH is not cured by parathyroidectomy, distinguishing it from primary hyperparathyroidism.</p>\r\n<p><strong>Urinary calcium excretion is increased (Option B): </strong>FHH is characterised by low urinary calcium, a diagnostic hallmark.</p>\r\n<p><strong>Acute pancreatitis is commonly associated with the condition (Option D):</strong> While rare adult cases may have pancreatitis, it is not common, especially in heterozygotes.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>FHH is a benign, autosomal dominant condition characterised by hypercalcaemia with low urinary calcium excretion and is not corrected by surgery.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Acts directly on renal, bone, and intestinal cells</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Acts directly on renal cells and indirectly on bone and intestinal cells</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Acts directly on renal and bone cells and indirectly on intestinal cells</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Has no direct actions on renal, bone, and intestinal cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following statements is true for the actions of parathyroid hormone (PTH)?</span></p>",
      "unique_key": "DT1198109",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>PTH acts directly on kidney and bone, and indirectly on the intestine via stimulation of 1&alpha;-hydroxylase and vitamin D activation.</p>\r\n<ul>\r\n<li>Parathyroid hormone (PTH) is a key regulator of calcium and phosphate metabolism and acts through PTH/PTHrP receptors, which are G protein&ndash;coupled receptors (GPCRs).</li>\r\n<li>Direct actions:\r\n<ul>\r\n<li>On kidney: increases calcium reabsorption and promotes phosphate excretion</li>\r\n<li>On bone: stimulates osteoblasts, which in turn activate osteoclasts, increasing bone resorption</li>\r\n</ul>\r\n</li>\r\n<li>Indirect action:\r\n<ul>\r\n<li>On intestine: PTH stimulates 1&alpha;-hydroxylase in the kidney, which converts 25(OH)D to 1,25(OH)2D (calcitriol)</li>\r\n<li>Calcitriol then increases intestinal calcium absorption</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>Explanation of other options:</p>\r\n<p>Acts directly on renal, bone, and intestinal cells (Option A): PTH does not act directly on intestinal cells.</p>\r\n<p>Acts directly on renal cells and indirectly on bone and intestinal cells (Option B): PTH directly stimulates bone resorption via osteoblast-osteoclast signalling.</p>\r\n<p>Has no direct actions on renal, bone, and intestinal cells (Option D): PTH acts directly on kidney and bone.</p>\r\n<p>Key Takeaway:</p>\r\n<p>PTH acts directly on kidney and bone, and indirectly enhances intestinal calcium absorption through activation of vitamin D.</p>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D - resistance disorders</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary hyperparathyroidism</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal insufficiency</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmunity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cause of hypocalcemia?</span></p>",
      "unique_key": "DT1198111",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198111,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Adrenal insufficiency is associated with <em>hypercalcemia</em>, not hypocalcemia, and thus is not a cause of low serum calcium:</p>\r\n<ul>\r\n<li>Hypocalcemia is commonly caused by:\r\n<ul>\r\n<li>Vitamin D-resistant rickets or hereditary resistance to vitamin D</li>\r\n<li>Secondary hyperparathyroidism, especially in chronic kidney disease</li>\r\n<li>Autoimmune hypoparathyroidism, such as in Autoimmune Polyendocrine Syndrome type 1 (APS-1)</li>\r\n<li>Autoantibodies against calcium-sensing receptor (CaSR)</li>\r\n</ul>\r\n</li>\r\n<li>Adrenal insufficiency causes mild hypercalcemia due to:\r\n<ul>\r\n<li>Volume depletion leading to decreased calcium clearance</li>\r\n<li>Possibly increased bone resorption</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Endocrine causes of hypercalcemia include:\r\n<ul>\r\n<li>Primary hyperparathyroidism</li>\r\n<li>Tertiary hyperparathyroidism</li>\r\n<li>Adrenal insufficiency</li>\r\n<li>Thyrotoxicosis</li>\r\n<li>Pheochromocytoma</li>\r\n</ul>\r\n</li>\r\n<li>In autoimmune disorders, hypocalcemia may arise due to destruction of parathyroid tissue or receptor-level defects.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Vitamin D-resistance disorders (Option A): </strong>Cause decreased calcium absorption &rarr; hypocalcemia</p>\r\n<p><strong>Secondary hyperparathyroidism (Option B):</strong> Common in CKD due to phosphate retention and low vitamin D &rarr; hypocalcemia</p>\r\n<p><strong>Autoimmunity (Option D):</strong> Can destroy parathyroid glands &rarr; hypoparathyroidism and hypocalcemia</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Adrenal insufficiency is a rare endocrine cause of <em>hypercalcemia</em>, not hypocalcemia.</p>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}